About this data
What it is
When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
Who files it
The insider, usually through the company, within two business days of the trade.
How current
We collect new filings throughout the day on SEC business days.
Worth knowing
Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.

All of this comes from public filings.

Open-market trades per day, last 30 days

05001,000Oct 17 · Purchases: 0Oct 17 · Sales: 0Oct 17Oct 18 · Purchases: 0Oct 18 · Sales: 0Oct 19 · Purchases: 29Oct 19 · Sales: 159Oct 20 · Purchases: 45Oct 20 · Sales: 209Oct 21 · Purchases: 38Oct 21 · Sales: 183Oct 21Oct 22 · Purchases: 50Oct 22 · Sales: 130Oct 23 · Purchases: 77Oct 23 · Sales: 126Oct 24 · Purchases: 1Oct 24 · Sales: 0Oct 25 · Purchases: 0Oct 25 · Sales: 0Oct 25Oct 26 · Purchases: 60Oct 26 · Sales: 171Oct 27 · Purchases: 27Oct 27 · Sales: 217Oct 28 · Purchases: 44Oct 28 · Sales: 135Oct 29 · Purchases: 35Oct 29 · Sales: 199Oct 29Oct 30 · Purchases: 68Oct 30 · Sales: 270Oct 31 · Purchases: 3Oct 31 · Sales: 0Nov 1 · Purchases: 2Nov 1 · Sales: 0Nov 2 · Purchases: 79Nov 2 · Sales: 826Nov 2Nov 3 · Purchases: 66Nov 3 · Sales: 337Nov 4 · Purchases: 67Nov 4 · Sales: 535Nov 5 · Purchases: 108Nov 5 · Sales: 458Nov 6 · Purchases: 137Nov 6 · Sales: 390Nov 6Nov 7 · Purchases: 0Nov 7 · Sales: 0Nov 8 · Purchases: 0Nov 8 · Sales: 0Nov 9 · Purchases: 110Nov 9 · Sales: 457Nov 10 · Purchases: 97Nov 10 · Sales: 406Nov 10Nov 11 · Purchases: 98Nov 11 · Sales: 330Nov 12 · Purchases: 54Nov 12 · Sales: 167Nov 13 · Purchases: 23Nov 13 · Sales: 28Nov 14 · Purchases: 0Nov 14 · Sales: 0Nov 14Nov 15 · Purchases: 0Nov 15 · Sales: 0
05001,000Oct 17 · Purchases: 0Oct 17 · Sales: 0Oct 17Oct 18 · Purchases: 0Oct 18 · Sales: 0Oct 19 · Purchases: 29Oct 19 · Sales: 159Oct 20 · Purchases: 45Oct 20 · Sales: 209Oct 21 · Purchases: 38Oct 21 · Sales: 183Oct 21Oct 22 · Purchases: 50Oct 22 · Sales: 130Oct 23 · Purchases: 77Oct 23 · Sales: 126Oct 24 · Purchases: 1Oct 24 · Sales: 0Oct 25 · Purchases: 0Oct 25 · Sales: 0Oct 25Oct 26 · Purchases: 60Oct 26 · Sales: 171Oct 27 · Purchases: 27Oct 27 · Sales: 217Oct 28 · Purchases: 44Oct 28 · Sales: 135Oct 29 · Purchases: 35Oct 29 · Sales: 199Oct 29Oct 30 · Purchases: 68Oct 30 · Sales: 270Oct 31 · Purchases: 3Oct 31 · Sales: 0Nov 1 · Purchases: 2Nov 1 · Sales: 0Nov 2 · Purchases: 79Nov 2 · Sales: 826Nov 2Nov 3 · Purchases: 66Nov 3 · Sales: 337Nov 4 · Purchases: 67Nov 4 · Sales: 535Nov 5 · Purchases: 108Nov 5 · Sales: 458Nov 6 · Purchases: 137Nov 6 · Sales: 390Nov 6Nov 7 · Purchases: 0Nov 7 · Sales: 0Nov 8 · Purchases: 0Nov 8 · Sales: 0Nov 9 · Purchases: 110Nov 9 · Sales: 457Nov 10 · Purchases: 97Nov 10 · Sales: 406Nov 10Nov 11 · Purchases: 98Nov 11 · Sales: 330Nov 12 · Purchases: 54Nov 12 · Sales: 167Nov 13 · Purchases: 23Nov 13 · Sales: 28Nov 14 · Purchases: 0Nov 14 · Sales: 0Nov 14Nov 15 · Purchases: 0Nov 15 · Sales: 0

Purchases Sales

By trade date. Insiders have two business days to file, so the most recent days fill in later.

Latest open-market insider trades

Reset

Showing: ticker ANAB

Latest open-market insider trades
TradedInsiderCompanyTypeSharesPriceValueFiling
Mar 30, 2026John P. Schmid
Director
ANAB
AnaptysBio, Inc.
Sale522$57.40$30.0K SaleForm 4 ↗
Mar 30, 2026John P. Schmid
Director
ANAB
AnaptysBio, Inc.
Sale7,527$56.70$426.8K SaleForm 4 ↗
Mar 30, 2026John P. Schmid
Director
ANAB
AnaptysBio, Inc.
Sale12,596$55.71$701.7K SaleForm 4 ↗
Mar 27, 2026Daniel Faga
President, CEO, Director
ANAB
AnaptysBio, Inc.
Sale100$65.99$6,599 SaleForm 4 ↗
Mar 27, 2026Daniel Faga
President, CEO, Director
ANAB
AnaptysBio, Inc.
Sale3,038$65.20$198.1K SaleForm 4 ↗
Mar 27, 2026Daniel Faga
President, CEO, Director
ANAB
AnaptysBio, Inc.
Sale3,155$64.19$202.5K SaleForm 4 ↗
Mar 27, 2026Daniel Faga
President, CEO, Director
ANAB
AnaptysBio, Inc.
Sale2,592$63.35$164.2K SaleForm 4 ↗
Mar 27, 2026Daniel Faga
President, CEO, Director
ANAB
AnaptysBio, Inc.
Sale1,012$62.15$62.9K SaleForm 4 ↗
Mar 27, 2026Daniel Faga
President, CEO, Director
ANAB
AnaptysBio, Inc.
Sale550$60.63$33.3K SaleForm 4 ↗
Mar 27, 2026Daniel Faga
President, CEO, Director
ANAB
AnaptysBio, Inc.
Sale490$59.62$29.2K SaleForm 4 ↗
Mar 27, 2026Daniel Faga
President, CEO, Director
ANAB
AnaptysBio, Inc.
Sale3,662$58.62$214.7K SaleForm 4 ↗
Mar 27, 2026Daniel Faga
President, CEO, Director
ANAB
AnaptysBio, Inc.
Sale2,570$57.91$148.8K SaleForm 4 ↗
Mar 27, 2026Daniel Faga
President, CEO, Director
ANAB
AnaptysBio, Inc.
Sale510$56.61$28.9K SaleForm 4 ↗
Feb 11, 2026Eric J. Loumeau
CHIEF LEGAL OFFICER
ANAB
AnaptysBio, Inc.
Sale10,000$54.00$540.0K SaleForm 4 ↗
Jan 15, 2026Magda Marquet
Director
ANAB
AnaptysBio, Inc.
Sale1,710$48.85$83.5K SaleForm 4 ↗
Jan 15, 2026Magda Marquet
Director
ANAB
AnaptysBio, Inc.
Sale9,290$48.12$447.0K SaleForm 4 ↗
Jan 8, 2026Paul F. Lizzul
Chief Medical Officer
ANAB
AnaptysBio, Inc.
Sale3,650$44.71$163.2K SaleForm 4 ↗
Jan 8, 2026Daniel Faga
President, CEO, Director
ANAB
AnaptysBio, Inc.
Sale14,281$44.71$638.5K SaleForm 4 ↗
Jan 8, 2026Dennis Mulroy
CHIEF FINANCIAL OFFICER
ANAB
AnaptysBio, Inc.
Sale2,515$44.71$112.4K SaleForm 4 ↗
Jan 8, 2026Eric J. Loumeau
CHIEF LEGAL OFFICER
ANAB
AnaptysBio, Inc.
Sale2,210$44.71$98.8K SaleForm 4 ↗
Jan 7, 2026Paul F. Lizzul
Chief Medical Officer
ANAB
AnaptysBio, Inc.
Sale2,235$45.11$100.8K SaleForm 4 ↗
Jan 7, 2026Daniel Faga
President, CEO, Director
ANAB
AnaptysBio, Inc.
Sale9,202$45.11$415.1K SaleForm 4 ↗
Jan 7, 2026Dennis Mulroy
CHIEF FINANCIAL OFFICER
ANAB
AnaptysBio, Inc.
Sale1,908$45.11$86.1K SaleForm 4 ↗
Jan 7, 2026Eric J. Loumeau
CHIEF LEGAL OFFICER
ANAB
AnaptysBio, Inc.
Sale500$47.23$23.6K SaleForm 4 ↗
Jan 7, 2026Eric J. Loumeau
CHIEF LEGAL OFFICER
ANAB
AnaptysBio, Inc.
Sale1,841$46.13$84.9K SaleForm 4 ↗
Jan 7, 2026Eric J. Loumeau
CHIEF LEGAL OFFICER
ANAB
AnaptysBio, Inc.
Sale5,281$45.38$239.7K SaleForm 4 ↗
Jan 7, 2026Eric J. Loumeau
CHIEF LEGAL OFFICER
ANAB
AnaptysBio, Inc.
Sale2,017$45.11$91.0K SaleForm 4 ↗
Jan 5, 2026Paul F. Lizzul
Chief Medical Officer
ANAB
AnaptysBio, Inc.
Sale4,219$43.26$182.5K SaleForm 4 ↗
Jan 5, 2026Daniel Faga
President, CEO, Director
ANAB
AnaptysBio, Inc.
Sale15,309$43.26$662.3K SaleForm 4 ↗
Jan 5, 2026Dennis Mulroy
CHIEF FINANCIAL OFFICER
ANAB
AnaptysBio, Inc.
Sale3,363$43.26$145.5K SaleForm 4 ↗
Jan 5, 2026Eric J. Loumeau
CHIEF LEGAL OFFICER
ANAB
AnaptysBio, Inc.
Sale2,983$43.26$129.0K SaleForm 4 ↗
Dec 23, 2025J. Anthony Ware
Director
ANAB
AnaptysBio, Inc.
Sale3,900$49.58$193.4K SaleForm 4 ↗
Dec 22, 2025Paul F. Lizzul
Chief Medical Officer
ANAB
AnaptysBio, Inc.
Sale1,500$50.00$75.0K SaleForm 4 ↗
Dec 22, 2025Dennis Mulroy
CHIEF FINANCIAL OFFICER
ANAB
AnaptysBio, Inc.
Sale10,000$50.00$500.0K SaleForm 4 ↗
Dec 22, 2025Eric J. Loumeau
CHIEF LEGAL OFFICER
ANAB
AnaptysBio, Inc.
Sale10,000$51.00$510.0K SaleForm 4 ↗
Dec 18, 2025Eric J. Loumeau
CHIEF LEGAL OFFICER
ANAB
AnaptysBio, Inc.
Sale141$46.99$6,626 SaleForm 4 ↗
Dec 17, 2025Eric J. Loumeau
CHIEF LEGAL OFFICER
ANAB
AnaptysBio, Inc.
Sale10,000$46.00$460.0K SaleForm 4 ↗
Dec 16, 2025Dennis Mulroy
CHIEF FINANCIAL OFFICER
ANAB
AnaptysBio, Inc.
Sale6,360$45.21$287.5K SaleForm 4 ↗
Dec 16, 2025Dennis Mulroy
CHIEF FINANCIAL OFFICER
ANAB
AnaptysBio, Inc.
Sale9,365$44.62$417.9K SaleForm 4 ↗
Dec 16, 2025Eric J. Loumeau
CHIEF LEGAL OFFICER
ANAB
AnaptysBio, Inc.
Sale4,195$45.24$189.8K SaleForm 4 ↗
Dec 16, 2025Eric J. Loumeau
CHIEF LEGAL OFFICER
ANAB
AnaptysBio, Inc.
Sale8,305$44.68$371.1K SaleForm 4 ↗
Sep 30, 2025Eric J. Loumeau
CHIEF LEGAL OFFICER
ANAB
AnaptysBio, Inc.
Sale8,240$29.00$239.0K SaleForm 4 ↗
Aug 8, 2025Hollings Renton
Director
ANAB
AnaptysBio, Inc.
Sale7,121$19.70$140.3K SaleForm 4 ↗
Aug 8, 2025Hollings Renton
Director
ANAB
AnaptysBio, Inc.
Sale3,110$19.44$60.5K SaleForm 4 ↗
Jul 2, 2025Hollings Renton
Director
ANAB
AnaptysBio, Inc.
Sale13,675$23.82$325.7K SaleForm 4 ↗
Jul 2, 2025Hollings Renton
Director
ANAB
AnaptysBio, Inc.
Sale7,250$23.09$167.4K SaleForm 4 ↗
Jun 18, 2025Dennis M. Fenton
Director
ANAB
AnaptysBio, Inc.
Sale3,015$23.97$72.3K SaleForm 4 ↗
Jun 18, 2025Hollings Renton
Director
ANAB
AnaptysBio, Inc.
Sale3,015$23.97$72.3K SaleForm 4 ↗
Jan 2, 2025EcoR1 Capital, LLC
Director, 10% owner
ANAB
AnaptysBio, Inc.
Buy6,646$12.95$86.1K BuyForm 4 ↗
Dec 31, 2024EcoR1 Capital, LLC
Director, 10% owner
ANAB
AnaptysBio, Inc.
Buy13,268$12.93$171.6K BuyForm 4 ↗

The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:05 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances